My top (>2%) positions in no particular order: BRKB, FB, PSHZF, AAPL, GOOG,
In:
Out:
Fixed income: 8%
Cash: 8%
Sectors
(kinda): Insurance (BRK): 13%, Malone/media: 1%, Banks/financials: 7%,
Stock funds: 9%, Industrial: 1%, Medical/pharma: 2%, Tech: 32%,
Various owner-operators (not included in other categories): 3%
New positions: RDBBY, ZNGA, DPZ, WLDBF, COST, FISV, SABR, PWFL, XBI, CPNG, CRCT
Positions increased: GOOGL, SHOP, VRTX, PSHZF, MELI, BABA, TTWO, MLSPF, V, ETSY
Positions reduced: MG, CHEK, PMD, DFS
Positions eliminated: MACE
Flip-flop: BIOX
I sold and reduced MG, CHEK, PMD, DFS, MACE mostly based on valuation considerations.
Added to GOOGL, VRTX, PSHZF, MELI, BABA, TTWO, MLSPF, V, ETSY at attractive valuations and to SHOP at unattractive valuation.
Bought positions in RDBBY, ZNGA, DPZ, WLDBF, COST, FISV, SABR, PWFL, CPNG, CRCT at so so valuations. Bought a position in XBI to track biotechs into which I don't have expertise to invest directly.
The above writeup misses a lot of SPACs and SPAC warrants which I decided not to discuss. SPACs are mostly held as cash equivalents (but not included in cash percentage above). SPAC warrants are held as long term options that may or might not have much value. In toto recently SPACs and warrants dropped from purchase prices and below $10 tentative cash value.
